U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT06819280) titled 'Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients with Advanced Colorectal Cancer' on Feb. 05.
Brief Summary: This study is a single arm, open design aimed at evaluating the safety and tolerability of Autologous Tumor-Infiltrating Lymphocyte (GT307) for treatment of patients with Advanced Colorectal Cancer,while evaluating pharmacokinetic characteristics and efficacy assessment to determine the optimal biological dose (OBD).
Study Start Date: June 28, 2024
Study Type: INTERVENTIONAL
Condition:
Adult
Intervention:
BIOLOGICAL: GT307 injection
GT307 injection to treat Advanced Colorectal Cancer
Recruitm...